Sign in

NCT06723028Active, not recruiting

Mobile Regulation of Craving Training (mROC-T) to Improve Dietary Intake in Rural Adolescent Girls

Source: ClinicalTrials.gov · Last updated 5 May 2026

Brief summary (registry, in English)

The goal of this clinical trial is to test if a regulation of craving training intervention in the form of a mobile phone app can increase fruit and vegetable intake in adolescent girls ages 14-18 years of age. The main questions it aims to answer are: 1. What is the effect of a mobile app version of the regulation of craving training intervention on healthy eating index scores over one year? 2. What is the effect of a mobile app version of the regulation of craving training intervention on body mass index, waist circumference, and blood glucose over one year? Researchers will compare the active regulation of craving training arm to a control fun food fact arm to see if the regulation of craving training improves HEI scores, BMI, and blood glucose over a year. Participants will be asked to play the regulation of craving training mobile app twice a week for a year.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
150 (estimated)
First submitted
3 Dec 2024
Start date
1 Feb 2025
Primary completion date
1 Feb 2026
Lead sponsor
University of Wyoming
NCT number
NCT06723028

What you commit to

  • Study type: Interventional
  • Planned participants: 150
  • From 1 Feb 2025 to the primary completion date, 1 Feb 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Lab values

  • Diagnosis from a medical profession of any of the following conditions, syndromes, diseases that may affect growth, glucose metabolism, blood clotting, cognitive development\*:
    • Any form of or history of cancer
    • Any form of diabetes (type I, II, insipidus)
    • Precocious puberty
    • Crohn's disease
    • Congenital heart defect
    • Cystic fibrosis
    • Cerebral palsy
    • Anorexia nervosa
    • Bulimia nervosa
    • Active infection
    • Fever
    • Hemophilia
    • Hydrocephalus
    • intestinal atresia
    • Jeune syndrome
    • Klippel-Trénaunay syndrome
    • Legg-Calvé-Perthes
    • Long QT syndrome
    • Muenke syndrome
    • Myelomeningocele
    • Necrotizing Enterocolitis
    • Neutropenia
    • Non-alcholoic fatty liver diease
    • Pfeiffer Syndrome
    • Saethre-Chotzen syndrome
    • Shwachman-Diamond syndrome
    • Spinal muscular atrophy
    • Sturge-Weber syndrome
    • Ulcerative Colitis
    • von Willebrand disease
    • Pancreatitis
    • Hurler syndrome
    • Niemann-Pick disease
    • Tay-Sachs disease
    • Gaucher disease
    • Krabbe disease
    • Zellweger syndrome
    • Wilson disease
    • Brachial Plexus Palsy
    • Brain Abscess or Spinal Abscess
    • Coarctation of the Aorta
    • Aortic stenosis
    • Ventricular septal defect
    • Patent ductus arteriosus or mitral valve abnormalities
    • Congenital Adrenal Hyperplasia
    • Craniofacial Microsomia
    • Duchenne Muscular Dystrophy
    • Dyskeratosis Congenita
    • Galactosemia
    • Maple syrup urine disease
    • Phenylketonuria
    • Turner syndrome
    • Prader-Wili disease
    • History of polycystic ovary syndrome
    • History of thyroid disease (either hyper or hypo)
    • History of adrenal disease (including Cushing's syndrome, Addison's disease)
    • Use of medications related to metabolism/weight such as insulin, corticosteroids, growth hormone, sulfonylurea, thiazolidinediones, beta blockers, calcium channel blockers, bupropion, reboxetine, molindone, clozapine, olanzapine, topiramate, zonisamide, valproate, carbamazepine, lithium, hypolipidemic drugs, highly-active antiretroviral therapies

Age

  • BMI percentile (for age and sex) \< 5th%

Other

  • Biologically male
  • Self-identify as male

Who the study is looking for

  • Biologically female
  • Female gender
  • Between the ages of 15y and 18y

Age in the registry: 15 years to 18 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University of Wyoming
Coordinator of this site? Confirm its status		LaramieUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.